logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Genomics
Filter

Genomics

Categories

Sectors

Locations

Exchange

Ping An’s healthtech arm cooperates with the Medical AI Lab Program of HKU

May 31, 2019

Life Science

U.S. Drug Spending Expected to Increase This Year and in Years to Come, Report Shows

May 30, 2019

Life Science

Johns Hopkins Launches Liquid Biopsy Company with $110 Million Series A

May 30, 2019

Life Science

Pfizer

Pfizer Upjohn Opens Global Headquarters in Shanghai

May 30, 2019

Life Science

Benchmark Botanics Forms $10 Million Cannabis JV with Yatai Pharma

May 30, 2019

Cannabis, Life Science

OCTAVE Institute Launches Multi-Year Global Collaboration With Skift

May 29, 2019

Life Science

Qilu Pharmaceutical Expanding Biopharmaceutical Production Capacity with ABEC Bioreactor Systems

May 29, 2019

Life Science

Harbour BioMed Signs mAb Discovery Deal with Global Top Ten Biopharma

May 29, 2019

Life Science

Xylyx Bio Announces Global Expansion, Adds 9 International Distributors to Meet Growing Demand

May 28, 2019

Life Science

Alphamab Oncology Announces Completion of US$60 Million Series B Financing

May 28, 2019

Life Science

Viela Bio Enters Strategic Collaboration with Hansoh Pharma to Develop and Commercialize Inebilizumab for Autoimmune Diseases and Hematologic Cancers in China,Viela Bio与豪森药业开展战略合作,开发和商业化Inebilizumab

Viela Bio Enters Strategic Collaboration with Hansoh Pharma to Develop and Commercialize Inebilizumab for Autoimmune Diseases and Hematologic Cancers in China

May 28, 2019

Life Science

Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for “Non-PVC Solid-Liquid Double Chamber Bag for Ceftazidime/Sodium Chloride Injection”

May 27, 2019

Life Science

CALECIM(R) forms a major partnership with Menarini Asia-Pacific to expand the presence of its stem cell skin care products in the region

May 27, 2019

Life Science

New Horizon Health Closes $66 Million C Round for Diagnostics

May 27, 2019

Life Science

Novartis’ SMA Gene Therapy Treatment Approved by FDA, Priced at $2.125 Million

May 25, 2019

Life Science

Incyte’s Jakafi gets FDA approval to treat Graft vs Host Disease

May 24, 2019

Life Science

Trump administration to roll back health-care protections for transgender people

May 24, 2019

Life Science

Apple bought a start-up that was working on monitoring asthma in children

May 24, 2019

Life Science

  • ‹‹ Previous
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada